This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Canaccord Financial Inc. Appoints Steve Buell Global Head Of Research

Will Oversee Canaccord Genuity's Global Research Offering

TORONTO, Nov. 6, 2012 /PRNewswire/ - Canaccord Financial Inc. (TSX: CF, LSE: CF., 'the Company') is pleased to announce that Steve Buell has been appointed Global Head of Research at Canaccord Genuity, where he will oversee the company's comprehensive research offering.

With research published from four geographies, Canaccord Genuity provides a global perspective on investing opportunities, and Mr. Buell will be entrusted with developing strategies to ensure clients benefit from the full scope of Canaccord's research, and implementing best practices across the company's global platform.

Mr. Buell joined Canaccord Genuity in 2010 as Managing Director and Director of U.S. Equity Research.  Prior to this, he served as Global Head of Equity Research at Piper Jaffray, Thomas Weisel Partners, Prudential Equity Group and ING Barings.  Steve has over 25 years of industry experience and holds a PhD in Neuroscience from the University of Rochester, School of Medicine and a BA in Biology from the University of Colorado.

Along with his new role, Mr. Buell will continue as Director of U.S. Research for Canaccord Genuity and will be based out of the Company's New York office.

" Steve Buell has world-class experience in leading and overseeing expansive research teams, and we're confident we can draw on his expertise to further develop the ways we provide our investment insights to our institutional and retail clients," said Paul Reynolds, President and CEO of Canaccord Financial Inc.  "With research coverage of approximately 1000 companies and sales and trading capabilities in six countries, we're focused on ensuring our clients receive the full benefit of Canaccord Genuity's global platform."

This announcement is the latest of several important management appointments aimed at strengthening the global integration of Canaccord Genuity's capital markets team.  In October, Phil Evershed was appointed Global Head of Investment Banking.  In September, Peter O'Malley joined as Chief Executive Officer of Canaccord Genuity Asia to oversee Canaccord operations in mainland China, Hong Kong and Singapore, and Alexis de Rosnay joined as Chief Executive Officer of Canaccord's U.K. and Europe operations.

ABOUT CANACCORD FINANCIAL INC.:

Through its principal subsidiaries, Canaccord Financial Inc. is a leading independent, full-service financial services firm, with operations in two principal segments of the securities industry: wealth management and global capital markets.  Since its establishment in 1950, Canaccord has been driven by an unwavering commitment to building lasting client relationships. We achieve this by generating value for our individual, institutional and corporate clients through comprehensive investment solutions, brokerage services and investment banking services.  Canaccord has offices in 12 countries worldwide, including Wealth Management offices located in Canada, Australia, the U.K. and Europe.  Canaccord Genuity, the international capital markets division, operates in Canada, the U.S., the U.K., France, Germany, Ireland, Italy, Hong Kong, mainland China, Singapore, Australia and Barbados.

Canaccord Financial Inc. is publicly traded under the symbol CF on the TSX and the symbol CF. on the London Stock Exchange.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs